• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Acerus Reports Fourth Quarter and Full Year 2019 Financial Results

    Danielle Edwards
    Mar. 04, 2020 06:01AM PST
    Biotech Investing

    Acerus Pharmaceuticals reported its financial results for the three and twelve-month period ended December 31, 2019. 

    Acerus Pharmaceuticals (TSX:ASP) reported its financial results for the three and twelve-month period ended December 31, 2019.

    As quoted in the press release:

    2019 Highlights

    • Amended and restated (“A&R”) partnership agreement with Aytu Bioscience (“Aytu”) becomes fully functional which should allow for accelerated growth of NATESTO® in the United States

    • Multiple scientific publications and congress presentations highlighting the unique clinical profile of NATESTO®

    • Avanafil New Drug Submission filed with Health Canada

    • Multiple financing transactions in 2019 and 2020 raising over $30 million to fund future growth

    Click here to read the full press release.

    tsx:aspacerus pharmaceuticals
    The Conversation (0)

    Go Deeper

    AI Powered
    Applied Therapeutics Reports Second Quarter 2025 Financial Results

    Applied Therapeutics Reports Second Quarter 2025 Financial Results

    A hand holding a double helix.

    Top 5 NASDAQ Genetics Stocks (Updated December 2023)

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES